Bionics Upsized $204M IPO: A Game-Changer for Diabetes Treatment

0
166

The IPO was spearheaded by BofA Securities Inc., Piper Sandler & Co., and Leerink Partners LLC as lead underwriters. Cooley LLP and Latham & Watkins LLP provided counsel to Beta Bionics and its underwriters, respectively.